Literature DB >> 10997828

Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men.

N Nakanishi1, K Nakamura, K Nakajima, K Suzuki, K Tatara.   

Abstract

The potential inverse association between coffee intake and serum gamma-glutamyltransferase (GGT) was examined in a cross-sectional study involving 1353 Japanese male office workers aged 35-59 years in Osaka, Japan. Those who had serum aminotransferases exceeding the normal range and/or who had been administered medical care for, or had a past history of, liver disease were excluded. Multiple linear regression analysis and analysis of covariance were used to control for confounding variables (age, body mass index, alcohol use, and cigarette smoking) and to examine possible interactions. From the linear regression analysis, coffee intake was inversely related to serum GGT levels independently of age, body mass index, alcohol intake, and cigarette smoking. All of the latter variables were also independently and positively associated with serum GGT levels. When the interactions between coffee and each of four covariates on serum GGT were evaluated by adding each interaction term to the above regression model, significant negative interactions were observed for age and cigarette smoking. From the analysis of covariance, lower levels of serum GGT associated with coffee consumption were more evident in the older age group and at the higher levels of cigarette smoking. These findings suggest that coffee consumption is inversely related to serum GGT and that coffee may inhibit the inducing effects of aging and possibly of smoking on serum GGT in the liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997828     DOI: 10.1023/a:1007683626665

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase.

Authors:  O Nilssen; O H Førde; T Brenn
Journal:  Am J Epidemiol       Date:  1990-08       Impact factor: 4.897

2.  Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee.

Authors:  K Poikolainen; E Vartiainen
Journal:  Am J Epidemiol       Date:  1997-12-15       Impact factor: 4.897

3.  Relations between reported alcohol consumption and certain biological variables in an "unselected" population.

Authors:  A Bagrel; A d'Houtaud; R Gueguen; G Siest
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

4.  Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis.

Authors:  R Joeres; H Klinker; H Heusler; J Epping; W Zilly; E Richter
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

Review 5.  Is serum gamma-glutamyltransferase a misleading test?

Authors:  R Penn; D J Worthington
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

6.  Re: "Alcohol, smoking, coffee, and cirrhosis" and "coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan".

Authors:  D S Sharp; N L Benowitz
Journal:  Am J Epidemiol       Date:  1995-03-01       Impact factor: 4.897

7.  Unexpected effects of coffee consumption on liver enzymes.

Authors:  E Casiglia; P Spolaore; G Ginocchio; G B Ambrosio
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

8.  Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group.

Authors:  F Pintus; P Mascia
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

9.  Carbohydrate-related regulation of the ethanol-induced increase in serum gamma-glutamyl transpeptidase activity in adult men.

Authors:  T Nakajima; S Ohta; H Fujita; N Murayama; A Sato
Journal:  Am J Clin Nutr       Date:  1994-07       Impact factor: 7.045

10.  Co-variation between biological markers and self-reported alcohol consumption. A two-year study of the relationship between changes in consumption and changes in the biological markers gamma-glutamyl transpeptidase (GGT) and average volume per erythrocyte (MCV) among problem drinkers.

Authors:  F Duckert; J Johnsen; A Amundsen; J Strømme; J Mørland
Journal:  Alcohol Alcohol       Date:  1992-09       Impact factor: 2.826

View more
  10 in total

Review 1.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

2.  Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.

Authors:  Qian Xiao; Rashmi Sinha; Barry I Graubard; Neal D Freedman
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

3.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

Review 4.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

5.  Serum gamma-glutamyltransferase is inversely associated with dietary total and coffee-derived polyphenol intakes in apparently healthy Japanese men.

Authors:  Chie Taguchi; Yoshimi Kishimoto; Kazuo Kondo; Kazushige Tohyama; Toshinao Goda
Journal:  Eur J Nutr       Date:  2017-10-07       Impact factor: 5.614

6.  Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Lynne R Wilkens; Shelly C Lu; Brenda Y Hernandez; Loïc Le Marchand; Brian E Henderson
Journal:  Gastroenterology       Date:  2014-10-08       Impact factor: 22.682

7.  Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study.

Authors:  K Yamashita; H Yatsuya; T Muramatsu; H Toyoshima; T Murohara; K Tamakoshi
Journal:  Nutr Diabetes       Date:  2012-04-02       Impact factor: 5.097

Review 8.  Coffee: The magical bean for liver diseases.

Authors:  Ryan D Heath; Mihir Brahmbhatt; Asli C Tahan; Jamal A Ibdah; Veysel Tahan
Journal:  World J Hepatol       Date:  2017-05-28

9.  Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.

Authors:  J C Dickson; A D Liese; C Lorenzo; S M Haffner; S M Watkins; S J Hamren; J K Stiles; L E Wagenknecht; A J Hanley
Journal:  BMC Gastroenterol       Date:  2015-07-28       Impact factor: 3.067

10.  Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.

Authors:  Yachiyo Sasaki; Satoko Ohfuji; Wakaba Fukushima; Akihiro Tamori; Masaru Enomoto; Daiki Habu; Shuji Iwai; Sawako Uchida-Kobayashi; Hideki Fujii; Susumu Shiomi; Norifumi Kawada; Yoshio Hirota
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.